Long-term effects of 1,25(OH)2D3 on clinical and biochemical derangements of divalent ions in dialysis patients.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001847:Bone Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002118:Calcium / Q000097:blood; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000503:physiopathology*; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010710:Phosphates; D000469:Alkaline Phosphatase; D008274:Magnesium; D002118:Calcium